Skip to content

Oropharyngeal Administration of Mother's Milk in Preterm Infants and Neonatal Infection

Impact of Oropharyngeal Administration of Mother's Milk Prior to Gavage Feeding on Hospital Acquired Neonatal Infection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03513146
Acronym
OPAMM
Enrollment
200
Registered
2018-05-01
Start date
2016-05-01
Completion date
2018-12-01
Last updated
2020-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Feeding Disorder, Neonatal SEPSIS, Preterm Infant

Brief summary

The protective effect of mother's milk and colostrum on oropharyngeal cavity is not achievable with gavage feeding. This may be increase the risk of colonization of the oropharyngeal cavity with pathogenic bacteria and subsequent increase in the risk of neonatal sepsis. We aim to study the impact of Oropharyngeal Administration of Mother's Milk (OPAMM) before gavage feeding on clinical outcome, bacterial colonization of the GIT of preterm infants with pathogenic bacteria. We also aim to study the immune-protective effect of OPAMM on the incidence of nosocomial sepsis.

Detailed description

Preterm, very low Birth Weight (VLBW), infants are at increased risk of feeding intolerance as they have shorter GIT with lower digestive, absorptive and motility capabilities than those of full term infants. Intolerance to enteral feeding has been associated with abdominal distention, initiation of an inflammatory cascade, edema of the bowel, and subsequent development of necrotizing enterocolitis (NEC). Oral feeding is the best and physiologic method for enteral nutrition of preterm infants. However, because of immaturity of suckling reflex and poor coordination between suckling and swallowing, gavage (oro-gastric or nasogastric tube feeding) has been used as an alternative method of enteral nutrition in preterm infants. The gut of preterm infants is frequently colonized with pathogenic bacteria due to prematurity, increase gut mucosal permeability, delayed initiation of feeding, formula feeding, and frequent use of antibiotics. This pathogenic bacteria increase the chance of development of nosocomial acquired sepsis and NEC. Mother's milk, particularly colostrum, is rich in cytokines and other immune agents that provide bacteriostatic, bacteriocidal, antiviral, anti-inflammatory and immunomodulatory protective agents against infection. Thus early gut priming and initiation of enteral feeding of preterm infants with mother's colostrum and milk decrease pathogenic bacterial colonization and subsequent development of sepsis and NEC. During breast feeding, mother's milk comes in contact with the mouth and oro-pharyngeal pouch which, theoretically, stimulate both oropharyngeal receptors that improves the motility, secretory and absorptive ability of the GIT. Furthermore, anti-inflammatory and pro inflammatory cytokines, which are present abundantly in mother's colostrum and milk, may exert an immuno-protective effect when they come in contact with oropharyngeal as well as GIT mucosa. We aim to study the impact of Oropharyngeal Administration of Mother's Milk (OPAMM) before gavage feeding on clinical outcome, bacterial colonization of the GIT of preterm infants with pathogenic bacteria. We also aim to study the immune-protective effect of OPAMM on the incidence of nosocomial sepsis.

Interventions

PROCEDUREOropharyngeal Administration of Mother's Milk (OPAMM)

0.2 ml of own mother's milk will be given by dropper to the oro-pharyngeal pouch, tongue and cheeks and the remaining amount will be given by the regular gavage feeding on intervals and amount regulated by the feeding protocol

Sponsors

Mansoura University Children Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

Microbiological assessment of bacterial colonization of the oropharyngeal cavity and the GIT will be masked

Intervention model description

Oropharyngeal Administration of mother's milk (OPAMM)

Eligibility

Sex/Gender
ALL
Age
1 Days to 90 Days
Healthy volunteers
No

Inclusion criteria

* Preterm infants delivered at less than 32 weeks gestation and less than 1500 grams birth weight will be included in the study

Exclusion criteria

1. Preterm infants \< 32 weeks gestation unable to be fed on own mothers' colostrum or milk. 2. Preterm infants with major congenital anomalies or chromosomal abnormalities. 3. Preterm infants delivered to mothers with confirmed chorioamnionitis 4. Preterm infants with confirmed early onset sepsis.

Design outcomes

Primary

MeasureTime frameDescription
Hospital Acquired late onset neonatal sepsisNeonatal care unit admissionCulture proven neonatal sepsis acquired during neonatal care admission

Secondary

MeasureTime frameDescription
Colonization of the oro-pharyngeal pouch with pathogenic micro-organismNeonatal care unit admissionThroat swab will be taken at the start of the study and at the end of full enteral feeding.
Colonization of the GIT with pathogenic micro-organismNeonatal care unit admissionStool culture will be taken at the start of the study and at the end of full enteral feeding.
Necrotizing enterocolitisNeonatal care unit admissionBell's stage II of necrotizing enterocolitis
Ventilator associated pneumoniaNeonatal care unit admissionClinical and radiological evidence of Ventilator associated pneumonia

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026